Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Acrivon Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −1 vs. Q3 2023
- Shares held
- 15.3M
- +215.2K (+1.4%) vs. Q3 2023
- Total value
- $74.5M
- −$69.8M (−48.4%) vs. Q3 2023
- New holders
- 3
- 16 more added
- Sold out
- 4
- 9 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,810,508 | $23.7M | 0.37% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $14.8M | 0.33% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 1,652,605 | $8.13M | 2.26% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,649,659 | $8.12M | 0.01% | −7980.0% | Reduced |
| Wellington Management Group LLP | 888,130 | $4.37M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 597,469 | $2.94M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 565,832 | $2.78M | 0.00% | +37,072+7.0% | Added |
| Vanguard Group Inc | 475,977 | $2.34M | 0.00% | +7,570+1.6% | Added |
| NEA Management Company, LLC | 430,252 | $1.29M | 0.09% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 226,375 | $1.11M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 189,200 | $931.0K | 0.00% | −359−0.2% | Reduced |
| State Street Corp | 133,276 | $655.7K | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 131,351 | $646.2K | 0.15% | +54,499+70.9% | Added |
| UBS Oconnor LLC | 93,443 | $459.7K | 0.01% | −11,557−11.0% | Reduced |
| Northern Trust Corp | 80,149 | $394.3K | 0.00% | +7,427+10.2% | Added |
| Charles Schwab Investment Management Inc | 68,501 | $337.0K | 0.00% | +840+1.2% | Added |
| Jacobs Levy Equity Management, Inc | 46,072 | $226.7K | 0.00% | +46,072 | New |
| JPMorgan Chase & Co | 33,343 | $164.0K | 0.00% | +6,771+25.5% | Added |
| Bridgeway Capital Management, LLC | 31,981 | $157.3K | 0.00% | +31,981 | New |
| D. E. Shaw & Co., Inc. | 31,939 | $157.1K | 0.00% | −14,811−31.7% | Reduced |
| Morgan Stanley | 25,631 | $126.1K | 0.00% | +20,688+418.5% | Added |
| Bank of New York Mellon Corp | 24,795 | $122.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 24,484 | $120.5K | 0.00% | +10,384+73.6% | Added |
| Exchange Traded Concepts, LLC | 13,289 | $65.4K | 0.00% | +3,370+34.0% | Added |
| Marex Group plc | 13,187 | $64.9K | 0.00% | +13,187 | New |
| Nuveen Asset Management, LLC | 11,821 | $58.2K | 0.00% | 00.0% | Unchanged |
| AAFCPAs Wealth Management, LLC | 10,678 | $52.5K | 0.03% | 00.0% | Unchanged |
| Bank of America Corp | 10,088 | $49.6K | 0.00% | +756+8.1% | Added |
| Rhumbline Advisers | 9,270 | $45.6K | 0.00% | −207−2.2% | Reduced |
| American International Group, Inc. | 4,321 | $21.3K | 0.00% | −17−0.4% | Reduced |
| Wells Fargo & Company | 2,691 | $13.2K | 0.00% | +530+24.5% | Added |
| Royal Bank of Canada | 2,488 | $12.0K | 0.00% | +927+59.4% | Added |
| New York State Common Retirement Fund | 2,273 | $11.2K | 0.00% | −24−1.0% | Reduced |
| Citigroup Inc | 2,047 | $10.1K | 0.00% | +1,817+790.0% | Added |
| Tower Research Capital LLC (TRC) | 2,018 | $9.93K | 0.00% | +763+60.8% | Added |
| California State Teachers Retirement System | 1,431 | $7.04K | 0.00% | −487−25.4% | Reduced |
| Amalgamated Bank | 1,231 | $6.00K | 0.00% | −113−8.4% | Reduced |
| Legal & General Group Plc | 839 | $4.13K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 806 | $3.97K | 0.00% | +518+179.9% | Added |
| Ameritas Investment Partners, Inc. | 695 | $3.42K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 800 | $3.00K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 260 | $1.28K | 0.00% | +122+88.4% | Added |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,564−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |